Sequent Scientific Ltd (BSE: 512529) is a Mumbai, Maharashtra-based company in the Pharmaceutical Contract Research Organization industry. With a market capitalisation of ₹9,866 Cr, it ranks #587 by market cap among the 6,137 Indian listed companies on FinBizNet. At ₹204.18 (as of 25 Oct 2026), the share price is 31.5% below its 52-week high of ₹298.00 and 14.6% above its 52-week low of ₹178.13. The share price is down 5.1% over one year and down 18.6% over three months.
| Current Price | ₹204.18 |
|---|---|
| Market Cap | ₹9,866 Cr |
| BSE Code | 512529 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Contract Research Organization |
| P/E Ratio | 55.1 |
| Return on Equity | 11.56% |
| Return on Assets | 6.00% |
| 52-Week Range | ₹178.13 – ₹298.00 |
| 1-Year Price Change | -5.1% |
| 3-Month Price Change | -18.6% |
| Beta (1Y) | 0.47 |
| Dividend Yield | 0.00% |
| Headquarters | Mumbai, Maharashtra |
| Website | www.sequent.in |
| Revenue | ₹946 Cr |
|---|---|
| Net Profit | ₹79 Cr |
| Net Margin | 8.4% |
| EPS (Basic) | ₹1.51 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Sequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides finished dosage formulation in therapeutic areas, such as nutrition, pain management, parasite control, antibiotics, and gut health for livestock, poultry, and companion animals. It also offers analytical services; and VET formulation services. The company was formerly known as PI Drugs & Pharmaceuticals Ltd. and changed its name to Sequent Scientific Limited in October 2009. The company was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited is a subsidiary of CA Harbor Investments.
1. Pharmaceuticals-This segment offers pharmaceutical products that are related to animal health. 2. Segment Adjustment-0 3. Analytical Services-This segment provides analytical and bio-analytical services primarily to pharmaceutical and consumer product companies. 4. Unallocated-This segment engages in woman healthcare business. It provides pharmaceutical products.
1. Pharmaceuticals-100%
Sequent Scientific Ltd is trading at ₹204.18, with a market capitalisation of ₹9,866 Cr.
Sequent Scientific Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Research Organization).
Sequent Scientific Ltd has a P/E of 55.1 and a return on equity of 11.56%.
Sequent Scientific Ltd is listed on the BSE under the scrip code 512529.
Sequent Scientific Ltd's share price is down 5.1% over one year and down 18.6% over three months. Its 52-week range is ₹178.13 to ₹298.00.
In Q1 FY27, Sequent Scientific Ltd reported revenue of ₹946 Cr and net profit of ₹79 Cr, with basic EPS of ₹1.51 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.